Wockhardt Raises ₹480 Crore to Accelerate Antibiotic Trials and Debt Reduction
In a strategic move to propel its drug development initiatives and alleviate debt burdens, pharmaceutical giant Wockhardt has successfully raised […]
DR-HABIL-KHORAKIWALA
In a strategic move to propel its drug development initiatives and alleviate debt burdens, pharmaceutical giant Wockhardt has successfully raised […]
